Physitrack PLC (PTRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Physitrack PLC (PTRK) has a cash flow conversion efficiency ratio of 0.060x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr597.76K ≈ $64.33K USD) by net assets (Skr9.90 Million ≈ $1.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Physitrack PLC market capitalisation for the company's overall valuation and market capitalisation.
Physitrack PLC - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Physitrack PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Physitrack PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Physitrack PLC ranked by their cash flow conversion efficiency. Explore PTRK cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eagle Plains Resources Ltd.
V:EPL
|
0.053x |
|
Auris Minerals Ltd
AU:AUR
|
-0.017x |
|
Stradim Espace Finances SA
PA:ALSAS
|
0.150x |
|
CAS Corporation
KQ:016920
|
0.034x |
|
Tempest Therapeutics Inc
NASDAQ:TPST
|
-9.243x |
|
Ranix INC
KQ:317120
|
0.001x |
|
Careplus Group Bhd
KLSE:0163
|
-0.058x |
|
DF Deutsche Forfait AG
XETRA:DFTK
|
-0.210x |
Annual Cash Flow Conversion Efficiency for Physitrack PLC (2017–2025)
The table below shows the annual cash flow conversion efficiency of Physitrack PLC from 2017 to 2025. View PTRK share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-11-30 | Skr9.92 Million ≈ $1.07 Million |
Skr3.88 Million ≈ $417.72K |
0.391x | +139.87% |
| 2024-11-30 | Skr19.17 Million ≈ $2.06 Million |
Skr3.13 Million ≈ $336.50K |
0.163x | +57.55% |
| 2023-11-30 | Skr25.57 Million ≈ $2.75 Million |
Skr2.65 Million ≈ $284.98K |
0.104x | +59.58% |
| 2022-11-30 | Skr22.37 Million ≈ $2.41 Million |
Skr1.45 Million ≈ $156.22K |
0.065x | +181.76% |
| 2021-11-30 | Skr28.65 Million ≈ $3.08 Million |
Skr659.81K ≈ $71.01K |
0.023x | -94.12% |
| 2020-11-30 | Skr5.19 Million ≈ $558.20K |
Skr2.03 Million ≈ $218.73K |
0.392x | -19.70% |
| 2019-11-30 | Skr1.03 Million ≈ $110.46K |
Skr500.89K ≈ $53.90K |
0.488x | -17.54% |
| 2018-11-30 | Skr1.19 Million ≈ $128.31K |
Skr705.60K ≈ $75.93K |
0.592x | +45.95% |
| 2017-11-30 | Skr1.35 Million ≈ $145.78K |
Skr549.27K ≈ $59.11K |
0.405x | -- |
About Physitrack PLC
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more